D-Cycloserine: A Novel Pharmacological Agent for Treating Anxiety Spectrum Disorders
نویسندگان
چکیده
D-Cycloserine: A Novel Pharmacological Agent for Treating Anxiety Spectrum Disorders Katherine Martin, M.D. Melanie Sisti, M.D. 12 A Novel Project in Student Education Snehal Bhatt, M.D. Heather Grigo, M.D. Anthony Tobia, M.D. Barbara Palmeri, M.D. 6 clickable The following is an interview with William Carpenter, Jr., M.D., on “Psychotic Disorders and DSM-V,” conducted by Maju Koola, M.D. Dr. Carpenter is a Professor of Psychiatry and Pharmacology at the University of Maryland School of Medicine, Director of the Maryland Psychiatric Research Center, and Editor-in-Chief of Schizophrenia Bulletin. Dr. Carpenter is also a member of the APA DSM-V Task Force and Chair of the APA DSM-V Psychotic Disorders Work Group. Dr. Koola is a third-year psychiatry resident at the University of New Mexico, Albuquerque, and this month’s Issue Editor. An Interview with William Carpenter, Jr., M.D.
منابع مشابه
Neuroenhancement of Exposure Therapy in Anxiety Disorders
Although exposure-based treatments and anxiolytic medications are more effective than placebo for treating anxiety disorders, there is still considerable room for further improvement. Interestingly, combining these two modalities is usually not more effective than the monotherapies. Recent translational research has identified a number of novel approaches for treating anxiety disorders using ag...
متن کاملNovel approaches in treatment of pediatric anxiety
Pediatric anxiety disorders have high prevalence rates and morbidity and are associated with considerable functional impairment and distress. They may be predictors for the development of other psychiatric disorders and, without intervention, are more likely to persist into adulthood. While evidence-based pharmacological and behavioral interventions are currently available, there remains a siza...
متن کاملCombined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches
BACKGROUND Despite its success in treating specific anxiety disorders, the effect of exposure therapy is limited by problems with tolerability, treatment resistance, and fear relapse after initial response. The identification of novel drug targets facilitating fear extinction in clinically relevant animal models may guide improved treatment strategies for these disorders in terms of efficacy, a...
متن کاملThe NMDA receptor partial agonist d-cycloserine does not enhance motor learning
RATIONALE There has recently been increasing interest in pharmacological manipulations that could potentially enhance exposure-based cognitive behaviour therapy for anxiety disorders. One such medication is the partial NMDA agonist d-cycloserine. It has been suggested that d-cycloserine enhances cognitive behaviour therapy by making learning faster. While animal studies have supported this view...
متن کاملState-of-the-art and future directions for extinction as a translational model for fear and anxiety.
Through advances in both basic and clinical scientific research, Pavlovian fear conditioning and extinction have become an exemplary translational model for understanding and treating anxiety disorders. Discoveries in associative and neurobiological mechanisms underlying extinction have informed techniques for optimizing exposure therapy that enhance the formation of inhibitory associations and...
متن کامل